305
Views
91
CrossRef citations to date
0
Altmetric
Original Research

Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide

, , , &
Pages 669-680 | Published online: 31 Jan 2018

References

  • XavierRPodolskyDUnravelling the pathogenesis of inflammatory bowel diseaseNature2007448715242743417653185
  • PodolskyDKInflammatory bowel diseaseN Engl J Med199132514100810161886623
  • BurischJMunkholmPThe epidemiology of inflammatory bowel diseaseScand J Gastroenterol201550894295125687629
  • HeadKAJurenkaJSInflammatory bowel disease part I: ulcerative colitis–pathophysiology and conventional and alternative treatment optionsAltern Med Rev20038324728312946238
  • FaubionWAJrLoftusEVJrHarmsenWSZinsmeisterARSandbornWJThe natural history of corticosteroid therapy for inflammatory bowel disease: a population-based studyGastroenterology2001121225526011487534
  • HanauerSBFeaganBGLichtensteinGRMaintenance infliximab for Crohn’s disease: the ACCENT I randomised trialLancet200235993171541154912047962
  • GisbertJPGonzález-LamaYMatéJ5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic reviewInflamm Bowel Dis200713562963817243140
  • SchäckeHSchotteliusADöckeW-DDissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effectsProc Natl Acad Sci2004101122723214694204
  • DebnathTKimDHLimBONatural products as a source of anti-inflammatory agents associated with inflammatory bowel diseaseMolecules20131867253727023783459
  • MadavSTripathiHTandanMishraSAnalgesic, antipyretic and antiulcerogenic effects of andrographolideIndian J Pharm Sci1995573121125
  • SinhaJMukhopadhyaySDasNBasuMKTargeting of liposomal andrographolide to L. donovani-infected macrophages in vivoDrug Deliv20007420921311195427
  • MelchiorJPalmSWikmanGControlled clinical study of standard-ized Andrographis paniculata extract in common cold – a pilot trialPhytomedicine19973431531823195187
  • ShenTYangWSYiY-SAP-1/IRF-3 targeted anti-inflammatory activity of andrographolide isolated from Andrographis paniculataEvid Based Complement Alternat Med2013201321073623840248
  • SheejaKShihabPKuttanGAntioxidant and anti-inflammatory activities of the plant Andrographis paniculata NeesImmunopharmacol Immunotoxicol200628112914016684672
  • WangJTanXFNguyenVSA quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasisMol Cell Proteomics201413387688624445406
  • WasmanSMahmoodAChuaLSAlshawshMAHamdanSAntioxidant and gastroprotective activities of Andrographis paniculata (Hempedu Bumi) in Sprague Dawley ratsIndian J Exp Biol2011491076777222013743
  • LiuWGuoWGuoLAndrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 responseInt Immunopharmacol201420233734524704625
  • SandbornWJTarganSRByersVSAndrographis paniculata extract (HMPL-004) for active ulcerative colitisAm J Gastroenterol20131081909823044768
  • YeLWangTTangLPoor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoproteinJ Pharm Sci2011100115007501721721007
  • RenKZhangZLiYPhysicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-β-cyclodextrinPharmazie200964851552019746840
  • BothirajaCShindeMBRajalakshmiSPawarAPEvaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVPJ Pharm Pharmacol200961111465147219903371
  • SermkaewNKetjindaWBoonmePPhadoongsombutNWiwattanapatapeeRLiquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculataEur J Pharm Sci201350345946623973887
  • YangTShengHHFengNPWeiHWangZTWangCHPreparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activityJ Pharm Sci2013102124414442524166599
  • GutiérrezJGonzálezCMaestroASoleIPeyCNollaJNanoemulsions: new applications and optimization of their preparationCurr Opin Colloid Interface Sci2008134245251
  • MadeneAJacquotMScherJDesobrySFlavour encapsulation and controlled release – a reviewInt J Food Sci Technol2006411121
  • VyasTKShahiwalaAAmijiMMImproved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulationsInt J Pharm200834719310117651927
  • LovelynCAttamaAACurrent state of nanoemulsions in drug deliveryJ Biomater Nanobiotechnol201125A626639
  • KottaSKhanAWPramodKAnsariSHSharmaRKAliJExploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugsExpert Opin Drug Deliv20129558559822512597
  • VandammeTFAntonNLow-energy nanoemulsification to design veterinary controlled drug delivery devicesInt J Nanomedicine2010586787321042549
  • WangXJiangYWangY-WHuangM-THoC-THuangQEnhancing anti-inflammation activity of curcumin through O/W nanoemulsionsFood Chem2008108241942426059118
  • LeongTWoosterTKentishSAshokkumarMMinimising oil droplet size using ultrasonic emulsificationUltrason Sonochem200916672172719321375
  • QianCMcClementsDJFormation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle sizeFood Hydrocoll201125510001008
  • JafariSMHeYBhandariBOptimization of nano-emulsions production by microfluidizationEur Food Res Technol20072255–6733741
  • SchultzSWagnerGUrbanKUlrichJHigh-pressure homogenization as a process for emulsion formationChem Eng Technol2004274361368
  • BouchemalKBrianconSPerrierEFessiHNano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimizationInt J Pharm20041–2208241251
  • FofariaNMQhattalHSSLiuXSrivastavaSKNanoemulsion formulations for anti-cancer agent piplartine – Characterization, toxicological, pharmacokinetics and efficacy studiesInt J Pharm20164981–2122226642946
  • TsaiY-MChang-LiaoW-LChienC-FLinL-CTsaiT-HEffects of polymer molecular weight on relative oral bioavailability of curcuminInt J Nanomedicine201272957296622745556
  • ChangC-WWangC-YWuY-THsuM-CEnhanced solubility, dissolution, and absorption of lycopene by a solid dispersion technique: the dripping pill delivery systemPowder Technol2016301641648
  • YorikiHNaitoYTakagiTHemin ameliorates indomethacin-induced small intestinal injury in mice through the induction of heme oxygenase-1J Gastroenterol Hepatol201328463263823216607
  • ImaokaHIshiharaSKazumoriHExacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout miceAm J Physiol Gastrointest Liver Physiol20102992G311G31920508157
  • GartiNYaghmurALeserMEClementVWatzkeHJImproved oil solubilization in oil/water food grade microemulsions in the presence of polyols and ethanolJ Agric Food Chem20014952552256211368635
  • KommuruTRGurleyBAKhanMReddyIKSelf-emulsifying drug delivery systems (SEDDS) of coenzyme Q 10: formulation development and bioavailability assessmentInt J Pharm2001212223324611165081
  • TangSYManickamSWeiTKNashiruBFormulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitationUltrason Sonochem201219233034521835676
  • TadrosTIzquierdoPEsquenaJSolansCFormation and stability of nano-emulsionsAdv Colloid Interface Sci2004108–109303318
  • ClementeZCastroVLSSMouraMAMJonssonCMFracetoLFToxicity assessment of TiO2 nanoparticles in zebrafish embryos under different exposure conditionsAquat Toxicol201414712913924418748
  • FlouryJDesrumauxALardièresJEffect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsionsInnov Food Sci Emerg Technol200012127134
  • AzumaKIppoushiKItoHHigashioHTeraoJCombination of lipids and emulsifiers enhances the absorption of orally administered quercetin in ratsJ Agric Food Chem20025061706171211879062
  • MonteiroLMLioneVFdo CarmoFADevelopment and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studiesInt J Nanomedicine201275175518223055729
  • ShonoYNishiharaHMatsudaYModulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranesJ Pharm Sci200493487788514999725
  • dos ReisSBde OliveiraCCAcedoSCAttenuation of colitis injury in rats using Garcinia cambogia extractPhytother Res200923332432918979524
  • KotakadiVSJinYHofsethABGinkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosisCarcinogenesis20082991799180618567620
  • El-AbharHSHammadLNGawadHSAModulating effect of ginger extract on rats with ulcerative colitisJ Ethnopharmacol2008118336737218571884
  • LeeK-CChangH-HChungY-HLeeT-YAndrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathwayJ Ethnopharmacol2011135367868421497192
  • Abu-GhefrehAACanatanHEzeamuzieCIIn vitro and in vivo anti-inflammatory effects of andrographolideInt Immunopharmacol20099331331819110075
  • XiaY-FYeB-QLiY-DAndrographolide attenuates inflammation by inhibition of NF-κB activation through covalent modification of reduced cysteine 62 of p50J Immunol200417364207421715356172
  • SinghUJialalIAnti-inflammatory effects of α-tocopherolAnn N Y Acad Sci20041031119520315753145